These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 9085256)
1. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256 [TBL] [Abstract][Full Text] [Related]
2. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Lan HY; Mu W; Yang N; Meinhardt A; Nikolic-Paterson DJ; Ng YY; Bacher M; Atkins RC; Bucala R Am J Pathol; 1996 Oct; 149(4):1119-27. PubMed ID: 8863661 [TBL] [Abstract][Full Text] [Related]
3. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926 [TBL] [Abstract][Full Text] [Related]
4. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production. Yang N; Nikolic-Paterson DJ; Ng YY; Mu W; Metz C; Bacher M; Meinhardt A; Bucala R; Atkins RC; Lan HY Mol Med; 1998 Jun; 4(6):413-24. PubMed ID: 10780884 [TBL] [Abstract][Full Text] [Related]
5. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Lan HY; Yang N; Nikolic-Paterson DJ; Yu XQ; Mu W; Isbel NM; Metz CN; Bucala R; Atkins RC Kidney Int; 2000 Feb; 57(2):499-509. PubMed ID: 10652026 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat. Miyazaki K; Isbel NM; Lan HY; Hattori M; Ito K; Bacher M; Bucala R; Atkins RC; Nikolic-Paterson DJ Clin Exp Immunol; 1997 May; 108(2):318-23. PubMed ID: 9158105 [TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats. Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492 [TBL] [Abstract][Full Text] [Related]
8. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Yu XQ; Fan JM; Nikolic-Paterson DJ; Yang N; Mu W; Pichler R; Johnson RJ; Atkins RC; Lan HY Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261 [TBL] [Abstract][Full Text] [Related]
9. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Hattori M; Nikolic-Paterson DJ; Miyazaki K; Isbel NM; Lan HY; Atkins RC; Kawaguchi H; Ito K Kidney Int Suppl; 1999 Jul; 71():S47-50. PubMed ID: 10412736 [TBL] [Abstract][Full Text] [Related]
11. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870 [TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease. Lv J; Huang XR; Klug J; Fröhlich S; Lacher P; Xu A; Meinhardt A; Lan HY Clin Sci (Lond); 2013 May; 124(10):627-37. PubMed ID: 23252627 [TBL] [Abstract][Full Text] [Related]
14. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Lan HY; Yu XQ; Yang N; Nikolic-Paterson DJ; Mu W; Pichler R; Johnson RJ; Atkins RC Kidney Int; 1998 Jan; 53(1):136-45. PubMed ID: 9453010 [TBL] [Abstract][Full Text] [Related]
15. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028 [TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived macrophage migration inhibitory factor mediates renal injury in anti-glomerular basement membrane glomerulonephritis. Yang H; Li J; Huang XR; Bucala R; Xu A; Lan HY Front Immunol; 2024; 15():1361343. PubMed ID: 38846956 [TBL] [Abstract][Full Text] [Related]
18. Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Rice EK; Tesch GH; Cao Z; Cooper ME; Metz CN; Bucala R; Atkins RC; Nikolic-Paterson DJ Kidney Int; 2003 Apr; 63(4):1265-75. PubMed ID: 12631343 [TBL] [Abstract][Full Text] [Related]
19. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Isbel NM; Hill PA; Foti R; Mu W; Hurst LA; Stambe C; Lan HY; Atkins RC; Nikolic-Paterson DJ Kidney Int; 2001 Aug; 60(2):614-25. PubMed ID: 11473644 [TBL] [Abstract][Full Text] [Related]
20. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]